Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Grainyhead-like (Grhl) Target Genes in Development and Cancer. | Int J Mol Sci | 2022 | 35269877 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors. | Front Immunol | 2022 | 35251007 | PubTator, text mining | PubMed |
| The importance of miRNA-630 in human diseases with an especial focus on cancers. | Cancer Cell Int | 2022 | 35248081 | PubTator, text mining | PubMed |
| CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcoma. | Cell Death Discov | 2022 | 35220396 | PubTator, text mining | PubMed |
| Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition. | Cancers (Basel) | 2022 | 35205643 | PubTator, text mining | PubMed |
| Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells. | Genes (Basel) | 2022 | 35205397 | PubTator, text mining | PubMed |
| TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease Patients. | Biomedicines | 2022 | 35203594 | PubTator, text mining | PubMed |
| Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma. | Biomedicines | 2022 | 35203444 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases. | Front Mol Biosci | 2022 | 35187086 | PubTator, text mining | PubMed |
| Exposure to GABAA Receptor Antagonist Picrotoxin in Pregnant Mice Causes Autism-Like Behaviors and Aberrant Gene Expression in Offspring. | Front Psychiatry | 2022 | 35185658 | PubTator, text mining | PubMed |
| DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells. | Int J Biol Sci | 2022 | 35173548 | PubTator, text mining | PubMed |
| Study on the effect of different types of sugar on lipid deposition in goose fatty liver. | Poult Sci | 2022 | 35172237 | PubTator, text mining | PubMed |
| Challenges of CRISPR-Based Gene Editing in Primary T Cells. | Int J Mol Sci | 2022 | 35163611 | PubTator, text mining | PubMed |
| Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma. | Int J Gen Med | 2022 | 35153510 | PubTator, text mining | PubMed |
| Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. | Semin Cancer Biol | 2022 | 35143990 | PubTator, text mining | PubMed |
| A knowledge graph to interpret clinical proteomics data. | Nat Biotechnol | 2022 | 35102292 | PubTator, text mining | PubMed |
| A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis. | Clin Transl Med | 2022 | 35064780 | PubTator, text mining | PubMed |
| 53BP1-ACLY-SLBP-coordinated activation of replication-dependent histone biogenesis maintains genomic integrity. | Nucleic Acids Res | 2022 | 35037047 | PubTator, text mining | PubMed |
| Significance of the lncRNAs MALAT1 and ANRIL in occurrence and development of glaucoma. | J Clin Lab Anal | 2022 | 35028972 | PubTator, text mining | PubMed |
| BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. | Nat Cell Biol | 2022 | 35027731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=18